| Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review L Ghosn, R Assi, T Evrenoglou, BS Buckley, N Henschke, K Probyn, ... Cochrane Database of Systematic Reviews, 2023 | 217 | 2023 |
| Efficacy and safety of COVID‐19 vaccines C Graña, L Ghosn, T Evrenoglou, A Jarde, S Minozzi, H Bergman, ... Cochrane Database of Systematic Reviews, 2022 | 212 | 2022 |
| Interleukin‐1 blocking agents for treating COVID‐19 M Davidson, S Menon, A Chaimani, T Evrenoglou, L Ghosn, C Graña, ... Cochrane Database of Systematic Reviews, 2022 | 43 | 2022 |
| Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study VT Nguyen, M Engleton, M Davison, P Ravaud, R Porcher, I Boutron BMC medicine 19, 1-14, 2021 | 26 | 2021 |
| Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials P Riviere, P Ripoll, J Barnier, R Vuillemot, G Ferrand, S Cohen-Boulakia, ... Journal of Clinical Epidemiology 130, 107-116, 2021 | 26 | 2021 |
| Low surgical complication rates in cochlear implantation for young children less than 1 year of age A Kalejaiye, G Ansari, G Ortega, M Davidson, HJ Kim The Laryngoscope 127 (3), 720-724, 2017 | 25 | 2017 |
| No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study M Davidson, T Evrenoglou, C Graña, A Chaimani, I Boutron Journal of Clinical Epidemiology 162, 90-97, 2023 | 2 | 2023 |
| Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials M Davidson, T Evrenoglou, C Graña, A Chaimani, I Boutron BMC Medical Research Methodology 24 (1), 9, 2024 | | 2024 |
| Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review L Ghosn, A Chaimani, T Evrenoglou, M Davidson, C Graña, C Schmucker, ... Cochrane database of systematic reviews, 2021 | | 2021 |
